Neurexins是神经特异性突触蛋白,Neurexin1β结构的异常与孤独症密切相关。为分析孤独症相关基因NRXN1β最小启动子和调节基因转录的功能元件,本文构建了含NRXN1β基因上游调控区不同区域的荧光素酶报告基因质粒,转染HEK293细胞后,利用检测双荧光素酶报告基因的转录活性以确定NRXN1β基因最小启动子区,进而筛选出相应的显著增强或抑制报告基因活性的功能区;同时,为鉴定顺式作用元件,利用基因定点突变技术对基因功能区内和临近DNA序列进行连续的碱基突变;最后,采用转录因子预测工具对启动子功能区内的转录调控元件进行分析。结果首次发现NRXN1β最小启动子区位于-88~+156 bp,-88~-73 bp和+156~+149 bp可增强启动子活性,+229~+419 bp可抑制启动子活性,且-84~-63 bp为能够显著性增强启动子活性的顺式作用元件,该区域可能存在DBP(Albumin D-site-binding protein,DBP)和ABF1(Autonomously replicating sequence-binding factor 1,ABF1)两个转录因子结合位点。
[1] 胡亚美, 江载芳. 诸福棠实用儿科学(第七版). 北京: 人民卫生出版社, 2002: 1956-1958.
[2] Sindi IA, Tannenberg RK, Dodd PR. Role for the neurexin-neuroligin complex in Alzheimer's disease. Neurobiol Aqinq , 2014, 35(4): 746-756.
[3] Bourne Y, Marchot P. The neuroligins and their ligands: from structure to function at the synapse. J Mol Neurosci , 2014, 53(3): 387-396.
[4] Xiang YY, Dong HH, Yang BB, MacDonald JF, Lu WY. Interaction of acetylcholinesterase with neurexin-1β regulates glutamatergic synaptic stability in hippocampal neurons. Mol Brain , 2014, 7: 15.
[5] Born G, Breuer D, Wang SP, Rohlmann A, Coulon P, Vakili P, Reissner C, Kiefer F, Heine M, Pape HC, Missler M. Modulation of synaptic function through the α-neurexin- specific ligand neurexophilin-1. Proc Natl Acad Sci USA , 2014, 111(13): 1274-1283.
[6] Bang ML, Owczarek S. A matter of balance: role of neurexin and neuroligin at the synapse. Neurochem Res , 2013, 38(6): 1174-1189.
[7] Rowen L, Young J, Birditt B, Kaur A, Madan A, Philipps DL, Qin SZ, Minx P, Wilson RK, Hood L, Graveley BR. Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. Genomics , 2002, 79(4): 587-597.
[8] Graf ER, Kang Y, Hauner AM, Craig AM. Structure function and splice site analysis of the synaptogenic activity of the neurexin-1β LNS domain. J Neurosci , 2006, 26(16): 4256-4265.
[9] Treutlein B, Gokce O, Quake SR, Südhof TC. Cartography of neurexin alternative splicing mapped by single-molecule long-read mRNA sequencing. Proc Natl Acad Sci USA , 2014, 111(13): E1291-E1299.
[10] Shen KC, Kuczynska DA, Wu IJ, Murray BH, Sheckler LR, Rudenko G. Regulation of neurexin 1beta tertiary structure and ligand binding through alternative splicing. Structure , 2008, 16(3): 422-431.
[11] Missler M, Südhof TC, Biederer T. Synaptic cell adhesion. Cold Spring Harb Perspectives Biol , 2012, 4(4): a005694.
[12] Futai K, Doty CD, Baek B, Ryu J, Sheng M. Specific Trans -synaptic interaction with inhibitory interneuronal neurexin underlies differential ability of neuroligins to induce functional inhibitory synapses. J Neurosci , 2013, 33(8): 3612-3623.
[13] Reissner C, Runkel F, Missler M. Neurexins. Genome Biol , 2013, 14(9): 213.
[14] Missler M, Südhof TC. Neurexins: Three genes and 1001 products. Trends Genet , 1998, 14(1): 20-26.
[15] Davletov BA, Krasnoperov V, Hata Y, Petrenko AG, Südhof TC. High affinity binding of α-latrotoxin to recombinant neurexin Iα. J Biol Chem , 1995, 270(41): 23903-23905.
[16] Missler M, Fernandez-Chacon R, Südhof TC. The making of neuexins. J Neurochem , 1998, 71(4): 1339-1347.
[17] Runkel F, Rohlmann A, Reissner C, Brand SM, Missler M. Promoter-like sequences regulating transcriptional activity in neurexin and neuroligin gene. J Neurochem , 2013, 127(1): 36-47.
[18] Miyake T, Loch CM, Li R. Identification of a multifunctional domain in autonomously replicating sequence-binding factor 1 required for transcriptional activation, DNA replication, and gene silencing. Mol Cell Biol , 2002, 22(2): 505-516.
[19] Klugmann M, Leichtlein CB, Symes CW, Klaussner BC, Brooks AI, Young D, During MJ. A novel role of circadian transcription factor DBP in hippocampal plasticity. Mol Cell Neurosci , 2006, 31(2): 303-314.
[20] Liu YL, Hu ZM, Xun GL, Peng Y, Lu LN, Xu XJ, Xiong ZM, Xia L, Liu DY, Li W, Zhao JP, Xia K. Mutation analysis of the NRXN1 gene in a Chinese autism cohort. J Psychiatr Res , 2012, 46(5): 630-634.
[21] Feng JN, Schroer R, Yan J, Song WJ, Yang CM, Bockholt A, Cook EH Jr, Skinner C, Schwartz CE, Sommer SS. High frequency of neurexin 1β signal peptide structural variants in patients with autism. Neurosci Lett , 2006, 409(1): 10-13.
[22] Autism Genome Project Consortium, Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, Liu XQ, Vincent J
